Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Net Income 2013–2025
Viridian Therapeutics Inc. annual/quarterly net income history and growth rate from 2013 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Viridian Therapeutics Inc. net income for the quarter ending March 31, 2026 was -104.9 M, a 20.70% increase year-over-year.
- Viridian Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -327.1 M, a 37.52% increase year-over-year.
- Viridian Therapeutics Inc. annual net income for 2025 was -342.6 M, a 26.91% increase from 2024.
- Viridian Therapeutics Inc. annual net income for 2024 was -269.9 M, a 13.55% increase from 2023.
- Viridian Therapeutics Inc. annual net income for 2023 was -237.7 M, a 83.05% increase from 2022.
- Viridian Therapeutics Inc. annual net income for 2022 was -129.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Viridian Therapeutics Inc. Net Income — FAQ
Viridian Therapeutics Inc. (VRDN) net income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Viridian Therapeutics Inc.'s net income?
Viridian Therapeutics Inc. (VRDN) reported net income of -$343M for fiscal 2025.
Where can I see VRDN's net income history?
The chart and table above show Viridian Therapeutics Inc.'s net income by year and by quarter, including the growth rate.